
Ticagrelor, prasugrel compared in ACS treated with PCI
(HealthDay)—For patients presenting with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI), a postrandomization subgroup analysis suggests that a prasugrel-based strategy is superior to ...
Jul 6, 2021
0
0